Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Carol Whelan et al.|Circulation|2016Cited by 2k
Systemic amyloidosisAshutosh Wechalekar, Philip N. Hawkins, Julian D. Gillmore|The Lancet|2015Cited by 984
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Angela Dispenzieri et al.|Journal of Clinical Oncology|2012Cited by 965
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac AmyloidosisMarianna Fontana, James Moon, Silvia Pica et al.|Circulation|2015Cited by 610
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisRaymond L. Comenzo, Giampaolo Merlini, Donna Reece et al.|Leukemia|2012Cited by 383